05.01.2015 Views

kısım 1 temel kalp yetersizliği - Rasim Enar

kısım 1 temel kalp yetersizliği - Rasim Enar

kısım 1 temel kalp yetersizliği - Rasim Enar

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Kalp Yetersizliğinde Elektriksel Tedavi 239<br />

21. Moss AJ, Hall WJ, Cannom DS et al. Improved survival<br />

with an implanted defibrillator sustained ventricular tachycardia.<br />

N Engl J Med 1996;335:1933-40<br />

22. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky<br />

EN, Hafley G, for Multicenter Unsustained Tachycardia<br />

Trial Investigators. A randomized study of the prevention<br />

of sudden death in patients with coronary artery disease N<br />

Engl J Med 1999;341:1882-90<br />

23. Buxton AE, Lee KL, Hafley G, et al. Relation of ejection<br />

fraction and inducible ventricular tachycardia to mode of<br />

death in patients with coronary artery disease. An analysis<br />

of patients enrolled in the multicenter unsustained tachycardia<br />

trial. Circulation 2003;108(1):67-72.<br />

24. Moss AJ, Zareba W, Hall WJ, et al, for Multicenter Automatic<br />

Defibrillator Implantation Trial ınvestigators(MADIT<br />

II). Prophylactıc implantation of a defibrillator in patients<br />

with myocardial infarction and reduced ejection fraction.<br />

N Engl J Med 2002;346:877-83.<br />

25. Wilber DJ, Zareba W, Hall WJ, et al:Time dependence of<br />

mortality risk and defibrillator benefit after myocardial infarction.<br />

Circulation 2004;109(9):1082-4.<br />

26. Pietrasik G, Goldenberg I, McNitt S, et al. Obesity as a risk<br />

factor for sustained ventricular tachyaarhythmias in MA-<br />

DIT II patients. J Cardiovasc Electrophysiol 2007;18(2):181-<br />

4.<br />

27. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate<br />

firing of the implanted defibrillator for ventricular<br />

tachycardia/fibrillation. J Am Coll Cardiol 2005;46(9):1712-<br />

20.<br />

28. Zwanzinger J, Hall WJ, Dick AW, et al. The cost-effectiveness<br />

of implantable defibrillators:results from the multicenter<br />

automatic defibrillator implantation trial J Am Coll<br />

Cardiol 2006;47:2310-8.<br />

29. Bigger JT, for CABG Patch trial Investigators. Prophylactic<br />

use of implanted cardiac defibrillators in patients at<br />

high risk for ventricular tachyarrhthmias. N Engl J Med<br />

1997;337:1569.<br />

30. Hohnloser SH, Kuck KH, Dorian P et al. Randomized trial<br />

of prophylactic implantable cardioverter defibrillator after<br />

acute myocardial infarction. N Engl J Med 2004;351:2481-<br />

2488.<br />

31. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone<br />

versus implantable cardioverter-defibrillator: randomized<br />

trial in patients with nonischemic dilated cardiomyopathy<br />

and asymptomatic nonsustained ventricular tachycardia<br />

–AMIOVIRT. J Am Coll Cardiol 2003;41(10):1707-<br />

12.<br />

32. Bansch D, Antz M, Boczor S, et al. Primary prevention of<br />

sudden death in idiopathic dilated cardiomyopathy:the Cardiomyopathy<br />

Trial(CAT). Circulation 2002;105(12):1453-8.<br />

33. Kadish A, Schaechter A, Subacius H, et al. Prophylactic<br />

defibrillator implantation in patients with nonischemic dilated<br />

cardiomyopathy N Engl J Med 2004;350(21):2151-8.<br />

34. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or implantable<br />

cardioverter-defibrillator for congestive heart failure<br />

N Engl J Med 2005;352(3):225-37.<br />

35. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable<br />

defibrillators for the prevention of mortality in patients<br />

with nonischemic cardiomyopathy. JAMA 2004;292:2874-<br />

2879.<br />

36. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic<br />

implantable cardioverter-defibrillator therapy in patients<br />

with left ventricular systolic dysfunction:a pooled<br />

analysis of 10 primary prevention trials. J Am Coll Cardiol<br />

2004;44(11):2166-72.<br />

37. Goldenberg I, Vyas AK, Hall WJ, et al. For the Multicenter<br />

Automatic Defibrillator Implantation Trial Investigators;<br />

Risk stratification for primary implantation of a cardioverter<br />

defibrillator in patients with ischemic left ventricular<br />

dysfunction. J Am Coll Cardiol 2008;51:288-96.<br />

38. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/<br />

AHA/HRS 2008 Guidelines for Device-Based Therapy<br />

of Cardiac Rhythm Abnormalities J Am Coll Cardiol<br />

2008;51:e1-62.<br />

39. The AVID investigators. A comparison of antiarrhythmic<br />

drug therapy with implantable defibrillators in patients resuscitated<br />

from near fatal ventricular arrhythmias. N Engl<br />

J Med 1997;337:1576-83.<br />

40. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable<br />

Defıbrillator Study(CIDS);a randomized trial of the<br />

implantable cardioverter defibrillator against amiodarone.<br />

Circulation 2000;102:748-54.<br />

41. Kuck KH, Cappato R, Siebels J, Ruppel R, Randomized<br />

comparison of antiarrhythmic drug therapy with implantable<br />

defibrillators in patients resuscitated from cardiac<br />

arrest:the Cardiac Arrest Study Hamburg (CASH). Circulation<br />

2000;102:748-54.<br />

42. Bokhari F, Newman D, Greene M et al. Long–term comparison<br />

of the implantable cardioverter defibrillator versus<br />

amiodarone. Circulation 2005;110:112-116.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!